Acquisitions Help Drive Gen-Probe Incorporated’s Q1 Revenues Up 17 Percent; Tops Street, Ups Lower End Of FY10 View

April 29 (Reuters) - Gen-Probe Inc (GPRO.O) reported better-than-expected first-quarter results, helped by a nearly 30 percent rise in sales of its clinical diagnostics products, and raised the lower end of its full-year outlook.